论文部分内容阅读
目的探讨肾上腺皮质腺瘤患者高血糖患病率及其接受外科手术治疗后血糖变化情况。方法 90例肾上腺皮质腺瘤患者作为研究组,同期90例健康体检人群作为对照组。记录治疗前研究组、对照组高血糖患病率以及研究组手术前后空腹血糖含量变化情况。结果研究组术前高血糖患病率(42.22%)显著高于对照组(15.56%),差异具有统计学意义(P<0.05);研究组肾上腺皮质腺瘤患者手术后空腹血糖检测结果仅为(7.24±0.62)mmol/L低于术前空腹血糖含量(8.45±0.51)mmol/L,差异具有统计学意义(P<0.05)。结论临床医生应准确掌握肾上腺皮质腺瘤与血糖含量相关性,采取多种措施积极确诊此类疾病后制定正确有效的治疗方案,维持患者机体血糖含量稳定并最终保障其生活质量。
Objective To investigate the prevalence of hyperglycemia in patients with adrenocortical adenoma and the changes of blood glucose after surgery. Methods 90 cases of adrenocortical adenoma patients as research group, 90 cases of healthy people over the same period as a control group. The pre-treatment study group, control group, the prevalence of hyperglycemia and the study group before and after fasting blood glucose levels. Results The prevalence of preoperative hyperglycemia (42.22%) in study group was significantly higher than that in control group (15.56%), the difference was statistically significant (P <0.05). The results of fasting blood glucose test in patients with adrenal adenocarcinoma in study group were only (7.24 ± 0.62) mmol / L was lower than preoperative fasting blood glucose (8.45 ± 0.51) mmol / L, the difference was statistically significant (P <0.05). Conclusion Clinicians should accurately grasp the correlation between adrenal cortical adenoma and blood glucose levels, take a variety of measures to actively diagnose these diseases to develop the correct and effective treatment options to maintain the stability of patients with blood glucose and ultimately ensure their quality of life.